abstract |
The invention relates to methods for the purification of flaviviruses, preferably West Nile Viruses. The invention also relates to methods of inactivating West Nile Viruses as well as to formulating and adjuvating West Nile Virus vaccines, wherein said formulations are suitable for use in humans. |